Biologics: Quality Developments & Manufacturing Summit
14-15

May 2020

Austria

Vienna

About

We are pleased to invite you to the Biologics: Quality Developments & Manufacturing Summit, scheduled for May 14-15, 2020. This premier B2B event provides the appropriate platform to engage and discuss ideas with your fellow peers, while facilitating a professional atmosphere and environment for good company representation and development. The Summit will shed light on the delivery of cost and quality efficient process development and manufacturing of biologics, including novel modalities. It is an honour and privilege to invite you to particip...

We are pleased to invite you to the Biologics: Quality Developments & Manufacturing Summit, scheduled for May 14-15, 2020. This premier B2B event provides the appropriate platform to engage and discuss ideas with your fellow peers, while facilitating a professional atmosphere and environment for good company representation and development. The Summit will shed light on the delivery of cost and quality efficient process development and manufacturing of biologics, including novel modalities. It is an honour and privilege to invite you to participate in this Summit. We look forward to welcoming you in May!

more info
Who Should Attend

Chief Executives, Vice Presidents, Directors, Heads, Leaders and Managers specialising in:

  • ADC
  • CMC
  • Engineering
  • GMP
  • Manufacturing
  • Plant/Site Management
  • Process engineers
  • Production
  • Supply Chain
  • Quality
  • Biologics
  • Contract Manufacturing
  • Facility Management
  • Investment
  • Novel Modalities
  • Process science
  • Procurement
  • Regulatory
  • QA/QC
Key Practical Learning Points of the Summit

Optimised biologics process development, manufacturing, cost and quality efficiency
Emerging science and technologies to facilitate development and manufacturing of high-quality and new modalities biologic drugs
Recent developments in relation to culture, QbD, ICH Guidelines, evolving quality of biologics production
Critical regulatory CMC strategies to empower successful biologics submissions
Innovative technical and operations approaches for biologics production in state-of-the-art facilities
Speakers
Dr. Ulrich Rümenapp, DE

Head of Launch Preparation and Coordination, Product Supply Biotech

Bayer AG

Morcos Loka, EG

Training Manager / and GMP Advisor

Minapharm Pharmaceuticals

Paolo Avalle, CH

Associate Principal Scientist | Process Analytical Technology

Merck

Dr. Matthias Henz, CH

Chief Quality Officer

BioAtrium

Dr. Qinghai Zhao, US

Vice President of Technical Development and Manufacturing

Forty Seven

Dr. Wenjie Cheng, US

Executive Director, CMC Management

WuXi Biologics

Dr. Paul Hanson, US

Head - Life Cycle Management, Strategy, and Innovation

Takeda

Josselyn Haas, FR

European Biomanufacturing Engineer Manager (MSAT EMEA)

Merck Group

Dr. Keith Chidwick, UK

Vice President (Technical)

PAREXEL

Álvaro Carpintero, ES

Partner

McKinsey & Company

Martin Mayer, AT

Smart Engineering Services and Digitalization

ZETA GmbH

Dr. Zoltán Kis, UK

Future Vaccines Manufacturing Hub, Research Associate / Centre for Process Systems Engineering, Department of Chemical Engineering

Imperial College London

Dr. Jose C. Menezes, PT

CEO

4Tune Engineering

Dr. Sebastian B. Teitz, DE

Product Manager & Scientific Coordinator

Asahi Kasei Bioprocess Europe

Amer Alghabban, UK

Managing Director

GxP Compliance and Training Partners (GCTP)

"